Showing results (351-360 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|June 21, 2019
A new family with transportinopathy: increased clinical heterogeneityCorrado Angelini, Roberta Marozzo, Elena Pinzan, et al.
Therapeutic Advances in Neurological Disorders|October 11, 2019
Repetitive transcranial magnetic stimulation in stroke rehabilitation: review of the current evidence and pitfallsFrancesco Fisicaro, Giuseppe Lanza, Alfio Antonio Grasso, et al.
Therapeutic Advances in Neurological Disorders|October 11, 2019
Progressive multiple sclerosis: latest therapeutic developments and future directionsSimon Faissner, Ralf Gold
Therapeutic Advances in Neurological Disorders|May 19, 2018
Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapyHarry Alexopoulos, Sofia Akrivou, Sotiria Mastroyanni, et al.
Therapeutic Advances in Neurological Disorders|June 2, 2018
Antisense oligonucleotides in neurological disordersClaudia D Wurster, Albert C Ludolph
Therapeutic Advances in Neurological Disorders|July 24, 2018
Intravenous thrombolysis for acute ischemic stroke in Greece: the Safe Implementation of Thrombolysis in Stroke registry 15-year experienceGeorgios Tsivgoulis, Odysseas Kargiotis, Jobst Rudolf, et al.
Therapeutic Advances in Neurological Disorders|May 17, 2017
Fingolimod initiation in multiple sclerosis patients is associated with potential beneficial cardiovascular autonomic effectsMax J Hilz, Ruihao Wang, Carmen de Rojas Leal, et al.
Therapeutic Advances in Neurological Disorders|May 17, 2017
Diclofenac potassium for oral solution (CAMBIA®) in the acute management of a migraine attack: clinical evidence and practical experienceShivang Joshi, Alan M Rapoport
Therapeutic Advances in Neurological Disorders|April 29, 2017
Daclizumab high-yield process in the treatment of relapsing-remitting multiple sclerosisJana Lizrova Preiningerova, Marta Vachova
Therapeutic Advances in Neurological Disorders|September 2, 2016
Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAINAntonios Bayas, Katrin Schuh, Monika Baier, et al.
Pageof 108